Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Visually significant haze after retreatment with photorefractive keratectomy with mitomycin-C following laser in situ keratomileusis
Visually significant haze after retreatment with photorefractive keratectomy with mitomycin-C following laser in situ keratomileusis JOURNAL OF CATARACT AND REFRACTIVE SURGERY Liu, A., Manche, E. E. 2010; 36 (9): 1599-1601Abstract
Photorefractive keratectomy (PRK) with the adjunctive use of mitomycin-C (MMC) for the treatment of residual refractive error after laser in situ keratomileusis (LASIK) has been shown to be safe and effective, with no occurrences of visually significant postoperative haze reported. We report a case of visually significant haze after PRK with MMC for residual myopia following LASIK.
View details for DOI 10.1016/j.jcrs.2010.06.004
View details for Web of Science ID 000281746200024
View details for PubMedID 20692575